Optum Rx Q3 2026 Earnings
Q3 earnings highlights focused on UnitedHealth Group's PBM segment, Optum Rx, which filled 21M fewer adjusted scripts in the quarter than in Q3 2025, while managing modest revenue growth of 0.6% and impressive operating margin expansion, driven by biosimilars and operational efficiencies.
